Profile picture

Doctor Adam Ioannou

UCL, Greater London (United Kingdom of Great Britain & Northern Ireland)
Follow
Logo ESC

Contributor content

CA-AI Echo – Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study
Presentation
CA-AI Echo – Diagnosis of cardiac amyloidosis on echocardiography using artificial intelligence: a multicentre international development and validation study
Read more
Who, what, where, when, why: imaging and the use of AI in monitoring CA
Presentation
Who, what, where, when, why: imaging and the use of AI in monitoring CA
Read more
Prognostic importance of the 6-minute walk test in transthyretin cardiac amyloidosis
Presentation
Prognostic importance of the 6-minute walk test in transthyretin cardiac amyloidosis
Read more
Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping
Presentation
Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping
Read more
Tracking multi-organ treatment response in systemic AL amyloidosis with cardiac magnetic resonance derived extracellular volume mapping
Presentation
Tracking multi-organ treatment response in systemic AL amyloidosis with cardiac magnetic resonance derived extracellular volume mapping
Read more
Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping
Presentation
Tracking treatment response in cardiac AL amyloidosis with native-T1 mapping
Read more
Automated analysis of echocardiograms at diagnosis is able to predict prognosis in ATTR cardiomyopathy
Presentation
Automated analysis of echocardiograms at diagnosis is able to predict prognosis in ATTR cardiomyopathy
Read more
Myocardial ischaemia in cardiac amyloidosis: a change of perspective
Presentation
Myocardial ischaemia in cardiac amyloidosis: a change of perspective
Read more
Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis
Presentation
Multi-imaging characterisation of cardiac phenotype in different types of amyloidosis
Read more
Changes in referral pathway and phenotypic status of patients diagnosed with ATTR cardiac amyloidosis during the past 20 years
Presentation
Changes in referral pathway and phenotypic status of patients diagnosed with ATTR cardiac amyloidosis during the past 20 years
Read more

ESC 365 is supported by

novartis Explore sponsored resources